Your browser doesn't support javascript.
loading
Unraveling the molecular and immunological landscape: Exploring signaling pathways in osteoporosis.
Amroodi, Morteza Nakhaei; Maghsoudloo, Mazaher; Amiri, Shayan; Mokhtari, Khatere; Mohseni, Parnaz; Pourmarjani, Azadeh; Jamali, Behdokht; Khosroshahi, Elaheh Mohandesi; Asadi, Saba; Tabrizian, Pouria; Entezari, Maliheh; Hashemi, Mehrdad; Wan, Runlan.
Affiliation
  • Amroodi MN; Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, department of orthopedic, school of medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Maghsoudloo M; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, Sichuan, China.
  • Amiri S; Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, department of orthopedic, school of medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Mokhtari K; Department of Cellular and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.
  • Mohseni P; Department of Pediatrics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Pourmarjani A; Department of Pediatrics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Jamali B; Department of microbiology and genetics, kherad Institute of higher education, Busheher, lran.
  • Khosroshahi EM; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Department of Genetics, Faculty of Advanced Science and Technology Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Asadi S; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Department of Genetics, Faculty of Advanced Science and Technology Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Tabrizian P; Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, department of orthopedic, school of medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: tabrizian.pouria@gmail.com.
  • Entezari M; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Department of Genetics, Faculty of Advanced Science and Technology Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Electronic address: ment
  • Hashemi M; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Department of Genetics, Faculty of Advanced Science and Technology Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Electronic address: mhas
  • Wan R; Department of Oncology, The Affiliated Hospital, Southwest Medical University, Luzhou 646000, China; Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, (Collaborative Innovation Center for Prevention of Cardiovasc
Biomed Pharmacother ; 177: 116954, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38906027
ABSTRACT
Osteoporosis, characterized by compromised bone density and microarchitecture, represents a significant global health challenge, particularly in aging populations. This comprehensive review delves into the intricate signaling pathways implicated in the pathogenesis of osteoporosis, providing valuable insights into the pivotal role of signal transduction in maintaining bone homeostasis. The exploration encompasses cellular signaling pathways such as Wnt, Notch, JAK/STAT, NF-κB, and TGF-ß, all of which play crucial roles in bone remodeling. The dysregulation of these pathways is a contributing factor to osteoporosis, necessitating a profound understanding of their complexities to unveil the molecular mechanisms underlying bone loss. The review highlights the pathological significance of disrupted signaling in osteoporosis, emphasizing how these deviations impact the functionality of osteoblasts and osteoclasts, ultimately resulting in heightened bone resorption and compromised bone formation. A nuanced analysis of the intricate crosstalk between these pathways is provided to underscore their relevance in the pathophysiology of osteoporosis. Furthermore, the study addresses some of the most crucial long non-coding RNAs (lncRNAs) associated with osteoporosis, adding an additional layer of academic depth to the exploration of immune system involvement in various types of osteoporosis. Finally, we propose that SKP1 can serve as a potential biomarker in osteoporosis.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Signal Transduction Limits: Animals / Humans Language: En Journal: Biomed Pharmacother Year: 2024 Document type: Article Affiliation country: Irán Country of publication: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Signal Transduction Limits: Animals / Humans Language: En Journal: Biomed Pharmacother Year: 2024 Document type: Article Affiliation country: Irán Country of publication: Francia